AMDULO Trademark
Trademark Overview
On Thursday, May 16, 2019, a trademark application was filed for AMDULO with the United States Patent and Trademark Office. The USPTO has given the AMDULO trademark a serial number of 79261511. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 12, 2026. This trademark is owned by Glaxo Group Limited. The AMDULO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
General Information
| Serial Number | 79261511 |
| Word Mark | AMDULO |
| Filing Date | Thursday, May 16, 2019 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, June 12, 2026 |
| Registration Number | 5917450 |
| Registration Date | Tuesday, November 26, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 10, 2019 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, June 12, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 11 - Company |
| Address | GB |
| Party Name | Glaxo Group Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 11 - Company |
| Address | GB |
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 11 - Company |
| Address | GB |
Trademark Events
| Event Date | Event Description |
| Thursday, June 27, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Wednesday, July 3, 2019 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Tuesday, July 23, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, July 27, 2019 | APPLICATION FILING RECEIPT MAILED |
| Thursday, August 1, 2019 | ASSIGNED TO EXAMINER |
| Monday, August 5, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 21, 2019 | NOTICE OF PUBLICATION |
| Tuesday, September 10, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 26, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, December 26, 2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Thursday, January 23, 2020 | FINAL DISPOSITION PROCESSED |
| Thursday, January 23, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, February 7, 2020 | NOTIFICATION PROCESSED BY IB |
| Wednesday, July 19, 2023 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Friday, May 23, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, June 12, 2026 | CANCELLED SECTION 71 |
